References
- Abdullah, N. N., et al., 2018. Human Papilloma Virus (HPV) self-sampling: do women accept it? Journal of Obstetrics and Gynaecology, 38 (3), 402–407.
- Allende, G., et al., 2019. Evaluation of the self-sampling for cervical cancer screening in Bolivia. BMC Public Health, 19 (1), 80.
- Bao, H. L., et al., 2018. Study on the coverage of cervical and breast cancer screening among women aged 35-69 years and related impact of socioeconomic factors in China, 2013. Zhonghua Liu Xing Bing Xue za Zhi, 39 (2), 208–212.
- Chaw, L. L., et al., 2022. Reasons for non-attendance to cervical cancer screening and acceptability of HPV self-sampling among Bruneian women: a cross-sectional study. Plos One, 17 (3), e0262213.
- Chinese Preventive Medicine Association Women’s Health Branch 2017. Guidelines for comprehensive prevention and control of cervical cancer. Beijing: People’s Medical Publishing House.
- Committee, H. C. A. P., 2019. (2019-07-15). Healthy China Initiative (2019–2030) 2022/10/05, 2022, from http://www.gov.cn/xinwen/2019-07/15/content_5409694.htm
- Fokom, D. J., et al., 2020. Feasibility of a community-based cervical cancer screening with ‘‘test and treat’’ strategy using self-sample for an HPV test: experience from rural Cameroon, Africa. International Journal of Cancer, 147 (1), 128–138.
- Goldstein, A., et al., 2020. Patient satisfaction with human papillomavirus self-sampling in a cohort of ethnically diverse and rural women in Yunnan Province, China. Journal of Lower Genital Tract Disease, 24 (4), 349–352.
- He, L. and He, J., 2020. Attitudes towards HPV self-sampling among women in Chengdu, China: a cross-sectional survey. Journal of Medical Screening, 27 (4), 201–206.
- Huang, J., et al., 2020. Problems and countermeasures in the implementation of national cervical and breast screening program for women in rural areas. Chinese General Practice, 13 (23), 1680–1686.
- Khoo, S. P., et al., 2021. The acceptability and preference of vaginal self-sampling for human papillomavirus (HPV) testing among a multi-ethnic Asian female population. Journal Article; Research Support, Non-U.S. Cancer Prevention Research, 14 (1), 105–112.
- Li, J., et al., 2018. The efficacy of human papillomavirus testing of vaginal self-sampling for cervical cancer screening. Chinese Journal of Clinical Obstetrics and Gynecology, 19 (4), 311–314.
- Liu, Z.C., et al., 2021. Interpretation on the report of Global Cancer Statistics 2020. Journal of Multidisciplinary Cancer Management, 7 (2), 1–14.
- Liu, L., 2022. Investigation and analysis of screening characteristics and awareness of cervical cancer in Haiyan County, Zhejiang Province. Modern Practical Medicine, 34 (2), 190–194.
- Madzima, T. R., Vahabi, M. and Lofters, A., 2017. Emerging role of HPV self-sampling in cervical cancer screening for hard-to-reach women Focused literature review. Canadian Family Physician, 63 (8), 597–601.
- Marshall, S., Vahabi, M. and Lofters, A., 2019. Acceptability, feasibility and uptake of hpv self-sampling among immigrant minority women: a focused literature review. Journal of Immigrant and Minority Health, 21 (6), 1380–1393.
- Nelson, E. J., et al., 2017. The acceptability of self-sampled screening for HPV DNA: a systematic review and meta-analysis. Sexually Transmitted Infections, 93 (1), 56–61
- Nishimura, H., et al., 2021. HPV self-sampling for cervical cancer screening: a systematic review of values and preferences. BMJ Global Health, 6 (5), e003743.
- Phoolcharoen, N., et al., 2018. Acceptability of self-sample human papillomavirus testing among Thai women visiting a colposcopy clinic. Journal of Community Health, 43 (3), 611–615.
- Polman, N. J., et al., 2019a. Experience with HPV self-sampling and clinician-based sampling in women attending routine cervical screening in the Netherlands. Preventive Medicine, 125, 5–11.
- Polman, N. J., et al., 2019b. Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial. The Lancet. Oncology, 20 (2), 229–238.
- Racey, C. S. and Gesink, D. C., 2016. Barriers and facilitators to cervical cancer screening among women in rural ontario, canada: the role of self-collected HPV testing. The Journal of Rural Health, 32 (2), 136–145.
- Sultana, F., et al., 2015. Women’s experience with home-based self-sampling for human papillomavirus testing. [Article]. BMC Cancer, 15, 849.
- WHO 2020. 2020-11-11). Cervical cancer 4/1, 2022, Available from: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer
- WHO 2021. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. 2nd edition. Geneva: World Health Organization.
- WHO 2022. (2022-02-22). Cervical cancer 9/3, 2022, Available from: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer
- Williams, D., et al., 2017. Women’s perspectives on human papillomavirus self-sampling in the context of the UK cervical screening programme. Health Expectations, 20 (5), 1031–1040.
- Winer, R. L., et al., 2016. Assessing acceptability of self-sampling kits, prevalence, and risk factors for human papillomavirus infection in American Indian women. Journal of Community Health, 41 (5), 1049–1061.
- Wong, E., et al., 2020. Acceptability and feasibility of HPV self-sampling as an alternative primary cervical cancer screening in under-screened population groups: a cross-sectional study. International Journal of Environmental Research and Public Health, 17 (17), 6245.
- Zhang, J., et al., 2021. Effectiveness of high-risk human papillomavirus testing for cervical cancer screening in China a multicenter, open-label, randomized clinical trial. JAMA Oncology, 7 (2), 263–270.
- Zhou, Y.Q., et al., 2016. Investigation on awareness and influencing factors of HPV self-sampling for cervical cancer screening of female in Shenzhen. Chinese Journal of Modern Nursing, 22 (17), 2426–2430.
- Zhao, Y., et al., 2019. Survey of the acceptance status of HPV self-sampling screening in female population for cervical cancer. Chinese Journal of Obstetrics and Gynecology, 54 (5), 312–317.